Ventricular tachycardia other disgnostic tests

Ventricular tachycardia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Ventricular Tachycardia from other Disorders
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography
Cardiac MRI
Other Diagnostic Tests
Treatment
Medical Therapy
Electrical Cardioversion
Ablation
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ventricular tachycardia other disgnostic tests On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ventricular tachycardia other disgnostic tests
CDC onVentricular tachycardia other disgnostic tests
Ventricular tachycardia other disgnostic tests in the news
Blogs on Ventricular tachycardia other disgnostic tests
to Hospitals Treating Ventricular tachycardia other disgnostic tests
Risk calculators and risk factors for Ventricular tachycardia other disgnostic tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Coronary angiography is used in the diagnostic evaluation of ventricular tachycardia in survivors of sudden cardiac death and life threatening ventricular tachycardia. Coronary angiography is used to rule out the presence of coronary artery disease in these patients.

Coronary Angiography

• Coronary angiography is used in survivors of sudden cardiac death and life threatening ventricular tachycardia for making decision about appropriate coronary revascularization .

2017 AHA/ACC/HRS Guidelines for Management of Patients With Ventricular Arrhythmia

Class I

"1. Coronary angiography is recommended in survivors of sudden cardiac arrest suspected ischemic heart disease for guiding decision about appropriate coronary revascularization (Level of Evidence C)"